NLRP3 and atherosclerosis: In addition, in ApoE–/– mice treated with the selective NLRP3 inhibitor MCC950 or silencing Nlrp3 by lentivirus, atherosclerosis progression was reduced, confirming NLRP3 inflammasome as a causative factor (81).